LMND Stock - Lemonade, Inc.
Unlock GoAI Insights for LMND
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $526.50M | $429.80M | $256.70M | $128.40M | $94.40M |
| Gross Profit | $172.70M | $90.20M | $28.40M | $22.90M | $20.40M |
| Gross Margin | 32.8% | 21.0% | 11.1% | 17.8% | 21.6% |
| Operating Income | $-203,900,000 | $-229,800,000 | $-294,800,000 | $-233,600,000 | $-120,800,000 |
| Net Income | $-202,200,000 | $-236,900,000 | $-297,800,000 | $-241,300,000 | $-122,300,000 |
| Net Margin | -38.4% | -55.1% | -116.0% | -187.9% | -129.6% |
| EPS | $-2.85 | $-3.40 | $-4.59 | $-3.94 | $-2.21 |
Lemonade, Inc. provides various insurance products in the United States and Europe. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. The company also offers renters, homeowners, pet, car, and life insurance products, as well as landlord insurance policies. In addition, it operates as an agent for other insurance companies. The company was formerly known as Lemonade Group, Inc. and changed its name to Lemonade, Inc. Lemonade, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2025 | Morgan Stanley | Upgrade | Equal Weight | $85 |
| August 13th 2025 | Cantor Fitzgerald | Initiation | Overweight | $60 |
| April 8th 2025 | Morgan Stanley | Downgrade | Underweight | $24 |
| November 20th 2024 | Morgan Stanley | Upgrade | Equal Weight | $42← $23 |
| November 7th 2024 | Keefe Bruyette | Downgrade | Underperform | $21← $18 |
| January 10th 2024 | TD Cowen | Initiation | Market Perform | $17 |
| December 1st 2023 | Oppenheimer | Downgrade | Perform | - |
| June 20th 2023 | Morgan Stanley | Initiation | Underweight | $14 |
| January 20th 2023 | BMO Capital Markets | Initiation | Underperform | $10 |
| November 17th 2022 | Keefe Bruyette | Initiation | Market Perform | $24 |
| July 18th 2022 | Piper Sandler | Downgrade | Neutral | $20← $24 |
Earnings History & Surprises
LMNDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | $-0.42 | — | — | — |
Q4 2025 | Nov 5, 2025 | $-0.72 | $-0.51 | +29.2% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $-0.81 | $-0.60 | +25.9% | ✓ BEAT |
Q2 2025 | May 6, 2025 | $-0.94 | $-0.86 | +8.5% | ✓ BEAT |
Q1 2025 | Feb 25, 2025 | $-0.61 | $-0.42 | +31.1% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $-1.02 | $-0.95 | +6.9% | ✓ BEAT |
Q3 2024 | Jul 30, 2024 | $-0.85 | $-0.81 | +4.7% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $-0.81 | $-0.67 | +17.3% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $-0.79 | $-0.61 | +22.8% | ✓ BEAT |
Q4 2023 | Nov 1, 2023 | $-0.93 | $-0.88 | +5.4% | ✓ BEAT |
Q3 2023 | Aug 2, 2023 | $-1.03 | $-0.97 | +5.8% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $-1.14 | $-0.95 | +16.7% | ✓ BEAT |
Q1 2023 | Feb 22, 2023 | $-1.17 | $-0.93 | +20.5% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $-1.36 | $-1.37 | -0.7% | ✗ MISS |
Q3 2022 | Aug 8, 2022 | $-1.36 | $-1.10 | +19.1% | ✓ BEAT |
Q2 2022 | May 9, 2022 | $-1.43 | $-1.21 | +15.4% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $-1.13 | $-1.14 | -0.9% | ✗ MISS |
Q4 2021 | Nov 8, 2021 | $-1.15 | $-1.08 | +6.1% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $-0.88 | $-0.90 | -2.3% | ✗ MISS |
Latest News
Citizens Maintains Market Outperform on Lemonade, Raises Price Target to $80
📈 PositiveMorgan Stanley Maintains Underweight on Lemonade, Raises Price Target to $53
➖ NeutralMorgan Stanley Maintains Underweight on Lemonade, Raises Price Target to $49
➖ NeutralLemonade shares are trading higher after the company reported better-than-expected Q3 results and raised its FY2025 sales guidance above estimates.
📈 PositiveLemonade stock climbs after strong Q3 earnings drives guidance boost
📈 PositiveLemonade Sees Q4 Sales $217.000M-$222.000M vs $213.820M Est
📈 PositiveLemonade Raises FY2025 Sales Guidance from $710.000M-$715.000M to $727.000M-$732.000M vs $713.719M Est
📈 PositiveLemonade Q3 EPS $(0.51) Beats $(0.73) Estimate, Sales $194.500M Beat $184.511M Estimate
📈 PositivePiper Sandler Maintains Neutral on Lemonade, Lowers Price Target to $55
➖ NeutralMorgan Stanley Maintains Underweight on Lemonade, Raises Price Target to $45
➖ NeutralPiper Sandler Maintains Neutral on Lemonade, Raises Price Target to $60
➖ NeutralBMO Capital Maintains Underperform on Lemonade, Raises Price Target to $42
➖ NeutralLemonade stock jumps after Q2 earnings top estimates, strong IFP guidance
📈 PositiveLemonade stock jumps after Q1 earnings beat, 2025 revenue guidance raised, despite wildfire impact
📈 PositiveFrequently Asked Questions about LMND
What is LMND's current stock price?
What is the analyst price target for LMND?
What sector is Lemonade, Inc. in?
What is LMND's market cap?
Does LMND pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to LMND for comparison